Legend Biotech Corporation (FRA:9LB)
17.60
-0.50 (-2.76%)
At close: Aug 26, 2026
Legend Biotech Employees
Legend Biotech had 3,200 employees as of June 30, 2026. The number of employees increased by 400 or 14.29% compared to the same quarter last year.
Employees
3,200
Change
400
Growth
14.29%
Revenue / Employee
€347,768
Profits / Employee
€25,028
Market Cap
3.44B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Jun 30, 2026 | 3,200 | 400 | 14.29% |
| Mar 31, 2026 | 3,100 | 400 | 14.81% |
| Dec 31, 2025 | 2,900 | 300 | 11.54% |
| Sep 30, 2025 | 2,900 | 500 | 20.83% |
| Jun 30, 2025 | 2,800 | 600 | 27.27% |
| Mar 31, 2025 | 2,700 | 700 | 35.00% |
| Dec 31, 2024 | 2,600 | 800 | 44.44% |
| Sep 30, 2024 | 2,400 | 700 | 41.18% |
| Jun 30, 2024 | 2,200 | 624 | 39.59% |
| Mar 31, 2024 | 2,000 | 610 | 43.88% |
| Dec 31, 2023 | 1,800 | 410 | 29.50% |
| Sep 30, 2023 | 1,700 | 310 | 22.30% |
| Jun 30, 2023 | 1,576 | - | - |
| Dec 31, 2022 | 1,390 | 319 | 29.79% |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Legend Biotech News
- 9 days ago - Legend Biotech price target lowered to $24 from $29 at TD Cowen - TheFly
- 9 days ago - Legend Biotech price target lowered to $78 from $80 at Barclays - TheFly
- 9 days ago - Legend Biotech downgraded to Perform from Outperform at Oppenheimer - TheFly
- 9 days ago - Oppenheimer downgrades Legend Biotech to Perform on CEO/competition overhangs - TheFly
- 9 days ago - Legend Biotech price target raised to $49 from $48 at Morgan Stanley - TheFly
- 15 days ago - Legend Biotech Earnings Call Transcript: Q2 2026 - Transcripts
- 15 days ago - Legend Biotech Earnings release: Q2 2026 - Filings
- 15 days ago - Legend Biotech Slides: Q2 2026 - Filings